Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial

Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial

Introduction Intracerebral haemorrhage (ICH) can be devastating and is a common cause of death and disability worldwide. Pre-ICH antiplatelet drug use is associated with a 27% relative increase in 1 month case fatality compared with patients not using antithrombotic drugs. We aim to assess the feasi...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Michael J R Desborough, Timothy J Coats, Philip M Bath, Rustam Al-Shahi Salman, Nikola Sprigg, Simon J Stanworth, Trish Hepburn, Paul M Brennan, Diane Havard, Robert A Dineen
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: BMJ Publishing Group 2020-11-01
Seri Bilgileri:BMJ Open
Online Erişim:https://bmjopen.bmj.com/content/10/11/e037555.full

Internet

https://bmjopen.bmj.com/content/10/11/e037555.full

Benzer Materyaller